Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations.
Flach J, Jann JC, Knaflic A, Riabov V, Streuer A, Altrock E, Xu Q, Schmitt N, Obländer J, Nowak V, Danner J, Mehralivand A, Hofmann F, Palme I, Jawhar A, Wuchter P, Metzgeroth G, Nolte F, Hofmann WK, Nowak D.
Flach J, et al.
Haematologica. 2021 Nov 1;106(11):2906-2917. doi: 10.3324/haematol.2020.254193.
Haematologica. 2021.
PMID: 33054116
Free PMC article.